Javad Moradpour
YOU?
Author Swipe
View article: Cost-Effectiveness of Infant and Maternal RSV Immunization Strategies, in British Columbia, Canada
Cost-Effectiveness of Infant and Maternal RSV Immunization Strategies, in British Columbia, Canada Open
Background Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in young children and results in significant healthcare burden and costs. To reduce the impact of RSV in this population, the monoclonal …
View article: The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake
The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake Open
Background The rapid development and rollout of COVID-19 vaccines helped reduce the pandemic’s mortality burden. The vaccine rollout, however, has been uneven; it is well known that vaccination rates tend to be lower in lower income countr…
View article: Overview of the global vaccine ecosystem
Overview of the global vaccine ecosystem Open
The bottlenecks in vaccination can be different for different countries, based on their income and geography. Policy makers need to identify the weaknesses of this ecosystem in different regions of the world and make sure there is adequate…
View article: Table of Contents
Table of Contents Open
View article: Home Remedies: How Should Canada Acquire Vaccines for the Next Pandemic?
Home Remedies: How Should Canada Acquire Vaccines for the Next Pandemic? Open
View article: The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies
The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies Open
Background The private versus public contribution to developing new health knowledge and interventions is deeply contentious. Proponents of commercial innovation highlight its role in late-stage clinical trials, regulatory approval, and wi…
View article: The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies
The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies Open
Background The private versus public contribution to developing new health knowledge and interventions is deeply contentious. Proponents of commercial innovation highlight its role in late-stage clinical trials, regulatory approval, and wi…